Skip to main content

Frost Phillip MD Et Al's Form 4 filing

Opko Health, Inc. (OPK) · filed Mar 1, 2022

Accession no.
0001209191-22-013836
Filed
Mar 1, 2022, 7:33 AM ET
Trade date
Feb 28, 2022
Filing delay
1 day
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 8 non-derivative transactions. Open-market purchases total $310.8K. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Frost Phillip MD Et AlCIK 0000898860Director, Officer (CEO & Chairman), 10% Owner
Frost Gamma Investments TrustCIK 000138089610% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 28, 2022Common StockPPurchaseAcquired+4,700$3.09+$14,499.5194,526,394Indirect
Feb 28, 2022Common StockPPurchaseAcquired+300$3.09+$927194,526,694Indirect
Feb 28, 2022Common StockPPurchaseAcquired+10,375$3.10+$32,110.63194,537,069Indirect
Feb 28, 2022Common StockPPurchaseAcquired+420$3.10+$1,302194,537,489Indirect
Feb 28, 2022Common StockPPurchaseAcquired+49,205$3.11+$152,781.53194,586,694Indirect
Feb 28, 2022Common StockPPurchaseAcquired+15,000$3.12+$46,725194,601,694Indirect
Feb 28, 2022Common StockPPurchaseAcquired+10,000$3.12+$31,200194,611,694Indirect
Feb 28, 2022Common StockPPurchaseAcquired+10,000$3.13+$31,250194,621,694Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)